Evidence map›Paper›PMID 29572181›Full record

ArticleLife sciences2018

Urinary bladder organ hypertrophy is partially regulated by Akt1-mediated protein synthesis pathway.

Li-Ya Qiao, Chunmei Xia, Shanwei Shen, Seong Ho Lee, Paul H Ratz, Matthew O Fraser, Amy Miner, John E Speich, Jeffrey J Lysiak, William D Steers

Abstract read
In one paragraph

Article in Life sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Li-Ya QiaoDepartment of Physiology and Biophysics, School of Medicine, Virginia Commonwealth University, Richmond, VA, United States. Electronic address: liya.qiao@vcuhealth.org.
Chunmei XiaDepartment of Physiology and Biophysics, School of Medicine, Virginia Commonwealth University, Richmond, VA, United States; Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University, Shanghai, China.
Shanwei ShenDepartment of Physiology and Biophysics, School of Medicine, Virginia Commonwealth University, Richmond, VA, United States.
Seong Ho LeeDepartment of Urology, University of Virginia, Charlottesville, VA, United States; Department of Urology, School of Medicine, Hallym University, Chuncheon, Republic of Korea.
Paul H RatzDepartment of Biochemistry, School of Medicine, Virginia Commonwealth University, Richmond, VA, United States.
Matthew O FraserDepartment of Surgery, Duke University Medical Center, Durham, NC, United States.
Amy MinerDepartment of Biochemistry, School of Medicine, Virginia Commonwealth University, Richmond, VA, United States.
John E SpeichDepartment of Mechanical and Nuclear Engineering, School of Engineering, Virginia Commonwealth University, Richmond, VA, United States.
Jeffrey J LysiakDepartment of Urology, University of Virginia, Charlottesville, VA, United States.
William D SteersDepartment of Urology, University of Virginia, Charlottesville, VA, United States.
Virginia Commonwealth University · USUniversity of Virginia · USDuke Medical Center · USShanghai Medical College of Fudan University · CN

Funding

Neurotrophins and Neuropeptides in Colon and Bladder HypersensitivityR01DK077917 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI QIAO, LIYA · 2008 to 2016
$2.8M
NIDDK NIH HHS R01 DK077917
6 · The paper itself

Abstract

aimsThe present study aims to investigate the role of Akt in the regulation of urinary bladder organ hypertrophy caused by partial bladder outlet obstruction (pBOO). MAIN

methodsMale rats were surgically induced for pBOO. Real-time PCR and western blot were used to examine the levels of mRNA and protein. A phosphoinositide 3-kinase (PI3K) inhibitor LY294002 was used to inhibit the activity of endogenous Akt. KEY

findingsThe urinary bladder developed hypertrophy at 2 weeks of pBOO. The protein but not mRNA levels of type I collagen and α-smooth muscle actin (αSMA) were increased in pBOO bladder when compared to sham control. The phosphorylation (activation) levels of Akt1 (p-Ser SIGNIFICANCE: pBOO-induced urinary bladder hypertrophy is attributable to fibrosis, smooth muscle cellular hypertrophy, and urothelium cell hyper-proliferation. Akt1-mediated protein synthesis in pBOO bladder contributes to type I collagen and αSMA but not PCNA up-regulation. Target of Akt1 is necessary but not sufficient in treatment of urinary bladder hypertrophy following pBOO.

Indexed as

AnimalsBiosynthetic PathwaysChromonesEnzyme InhibitorsFibrosisHypertrophyMaleMorpholinesOrgan SizePhosphoinositide-3 Kinase InhibitorsProto-Oncogene Proteins c-aktRatsRats, Sprague-DawleyRNA, MessengerUrinary BladderUrinary Bladder Neck Obstruction2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneAkt1 protein, ratChromonesEnzyme InhibitorsMorpholinesPhosphoinositide-3 Kinase InhibitorsProto-Oncogene Proteins c-aktRNA, MessengerAkt1Detrusor thickeningpBOOProtein synthesisUrinary bladder

Identifiers

PMID29572181
PMCPMC5955831
OpenAlexW2791628360

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.